Short answer
CARLSMED, INC. (CARL) filed its Q1 2026 10-Q quarterly report on May 5, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $16M with net income of −$9M.
Q1 2026 key financials · XBRL
- Revenue
- $16M
- Net income
- −$9M
- Operating margin
- -57.6%
- Gross margin
- 77.1%
- EPS (diluted)
- −$0.32
Source: XBRL data from the CARLSMED, INC. (CARL) Q1 2026 10-Q on SEC EDGAR. USD.
CARLSMED, INC. Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- No material risk-factor changes identified; filing references 10-K risks filed February 25, 2026
- Regulatory risk: aprevo Technology Platform requires applicable regulatory approvals
- Reimbursement risk: third-party payor strategy may not be maintained or improved
- Operational risk: reliance on a limited number of contract manufacturing organizations
- Financial risk: additional financing may be required before achieving profitability
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other CARLSMED, INC. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.